Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm

IF 5.2 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
Journal of Integrative Medicine-Jim Pub Date : 2026-09-01 Epub Date: 2026-06-05 DOI:10.1016/j.joim.2026.06.001
Jing-wen Mu, Ting Cheng, Liang Hu, Biao Lei, Yu-he Ma, Yu Cui, Yan-chun Peng, Wen-bo Huang, You-wen Ge, Ling-Pei Ho, Yue-juan Zheng
{"title":"Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm","authors":"Jing-wen Mu,&nbsp;Ting Cheng,&nbsp;Liang Hu,&nbsp;Biao Lei,&nbsp;Yu-he Ma,&nbsp;Yu Cui,&nbsp;Yan-chun Peng,&nbsp;Wen-bo Huang,&nbsp;You-wen Ge,&nbsp;Ling-Pei Ho,&nbsp;Yue-juan Zheng","doi":"10.1016/j.joim.2026.06.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Post-influenza bacterial infection is associated with higher severity and mortality rates. Qingfei Paidu decoction (QFPDD) has demonstrated efficacy as an anti-inflammatory therapeutic agent specifically for influenza. However, its role in bacterial secondary infection remains unclear. This study aimed to investigate the protective effects and underlying mechanisms of QFPDD in a mouse model of post-influenza bacterial infection.</div></div><div><h3>Methods</h3><div>A mouse model of post-influenza bacterial infection was established to evaluate the therapeutic effects of QFPDD. QFPDD was administered prior to the full establishment of secondary bacterial infection. Body weight, body temperature, lung indexes and pulmonary bacterial load were evaluated by lung weighing and colony counting of lung tissue homogenates. Single-cell ribonucleic acid sequencing (scRNA-seq) was performed to characterize immune cell populations and cytokine expression levels in lung tissues. Neutrophil activation, neutrophil extracellular trap (NET) formation and coagulation-related markers were examined using molecular and biochemical approaches. In vitro, pam<sub>3</sub>cys-ser-lys<sub>4</sub> (Pam3CSK4)-stimulated macrophages were used to assess cytokine production, while the expression of phagocytic receptors was evaluated in macrophages and neutrophils following Pam3CSK4 or heat-killed <em>Staphylococcus aureus</em> stimulation. In addition, phorbol 12-myristate 13-acetate (PMA)-stimulated neutrophils were utilized to assess the production of reactive oxygen species (ROS) and the activation of signaling pathways.</div></div><div><h3>Results</h3><div>QFPDD prevented body weight loss, reduced lung indexes, decreased lung bacterial load and alleviated hypothermia in secondary infected mice. ScRNA-seq analysis revealed decreased cytokine scores in the lungs following QFPDD treatment, with neutrophils exhibiting the highest cytokine scores among the 18 identified cell populations. QFPDD downregulated inflammatory mediators in neutrophils. Furthermore, QFPDD reduced the expression of xanthine oxidase, myeloperoxidase, citrullinated histone H3, and peptidyl arginine deiminase 4, accompanied by decreased S100 calcium-binding protein A8 and S100 calcium-binding protein A9 levels, suggesting that QFPDD can be associated with the reduced formation of NETs. QFPDD also decreased platelet activation and hypercoagulation markers. In vitro, QFPDD inhibited cytokine and chemokine production in macrophages and suppressed ROS generation and extracellular signal-regulated protein kinase phosphorylation in neutrophils. In addition, QFPDD significantly enhanced the expression of phagocytic receptors in macrophages and neutrophils.</div></div><div><h3>Conclusion</h3><div>QFPDD confers protection against post-influenza bacterial infection by inhibiting the formation of NETs and cytokine storm, highlighting its potential as a candidate for further investigation in the prevention and treatment of this condition.</div><div><br>Please cite this article as: Mu JW, Cheng T, Hu L, Lei B, Ma YH, Cui Y, Peng YC, Huang WB, Ge YW, Ho LP, Zheng YJ. Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm. <em>J Integr Med</em>. 2026; 24(5):769–784.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"24 5","pages":"Pages 769-784"},"PeriodicalIF":5.2000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Medicine-Jim","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2095496426000798","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Post-influenza bacterial infection is associated with higher severity and mortality rates. Qingfei Paidu decoction (QFPDD) has demonstrated efficacy as an anti-inflammatory therapeutic agent specifically for influenza. However, its role in bacterial secondary infection remains unclear. This study aimed to investigate the protective effects and underlying mechanisms of QFPDD in a mouse model of post-influenza bacterial infection.

Methods

A mouse model of post-influenza bacterial infection was established to evaluate the therapeutic effects of QFPDD. QFPDD was administered prior to the full establishment of secondary bacterial infection. Body weight, body temperature, lung indexes and pulmonary bacterial load were evaluated by lung weighing and colony counting of lung tissue homogenates. Single-cell ribonucleic acid sequencing (scRNA-seq) was performed to characterize immune cell populations and cytokine expression levels in lung tissues. Neutrophil activation, neutrophil extracellular trap (NET) formation and coagulation-related markers were examined using molecular and biochemical approaches. In vitro, pam3cys-ser-lys4 (Pam3CSK4)-stimulated macrophages were used to assess cytokine production, while the expression of phagocytic receptors was evaluated in macrophages and neutrophils following Pam3CSK4 or heat-killed Staphylococcus aureus stimulation. In addition, phorbol 12-myristate 13-acetate (PMA)-stimulated neutrophils were utilized to assess the production of reactive oxygen species (ROS) and the activation of signaling pathways.

Results

QFPDD prevented body weight loss, reduced lung indexes, decreased lung bacterial load and alleviated hypothermia in secondary infected mice. ScRNA-seq analysis revealed decreased cytokine scores in the lungs following QFPDD treatment, with neutrophils exhibiting the highest cytokine scores among the 18 identified cell populations. QFPDD downregulated inflammatory mediators in neutrophils. Furthermore, QFPDD reduced the expression of xanthine oxidase, myeloperoxidase, citrullinated histone H3, and peptidyl arginine deiminase 4, accompanied by decreased S100 calcium-binding protein A8 and S100 calcium-binding protein A9 levels, suggesting that QFPDD can be associated with the reduced formation of NETs. QFPDD also decreased platelet activation and hypercoagulation markers. In vitro, QFPDD inhibited cytokine and chemokine production in macrophages and suppressed ROS generation and extracellular signal-regulated protein kinase phosphorylation in neutrophils. In addition, QFPDD significantly enhanced the expression of phagocytic receptors in macrophages and neutrophils.

Conclusion

QFPDD confers protection against post-influenza bacterial infection by inhibiting the formation of NETs and cytokine storm, highlighting its potential as a candidate for further investigation in the prevention and treatment of this condition.

Please cite this article as: Mu JW, Cheng T, Hu L, Lei B, Ma YH, Cui Y, Peng YC, Huang WB, Ge YW, Ho LP, Zheng YJ. Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm. J Integr Med. 2026; 24(5):769–784.
清肺排毒汤是一种复方中草药,通过抑制中性粒细胞胞外陷阱和细胞因子风暴的形成来预防流感后细菌感染。
目的:流感后细菌感染与较高的严重程度和死亡率相关。清肺排毒汤(QFPDD)是一种抗炎治疗流感的特效药。然而,其在继发性细菌性感染中的作用尚不清楚。本研究旨在探讨QFPDD对流感后细菌感染小鼠模型的保护作用及其潜在机制。方法:建立流感后细菌感染小鼠模型,评价芪散泻剂的治疗效果。在继发性细菌感染完全确定之前给予QFPDD。通过肺称重和肺组织匀浆菌落计数评估体重、体温、肺指数和肺部细菌负荷。单细胞核糖核酸测序(scRNA-seq)表征肺组织中免疫细胞群和细胞因子表达水平。使用分子和生化方法检测中性粒细胞活化、中性粒细胞胞外陷阱(NET)形成和凝固相关标志物。在体外,Pam3CSK4 -ser-lys4 (Pam3CSK4)刺激巨噬细胞评估细胞因子的产生,而在Pam3CSK4或热杀伤金黄色葡萄球菌刺激巨噬细胞和中性粒细胞后,评估吞噬受体的表达。此外,利用phorbol 12-肉豆蔻酸13-乙酸酯(PMA)刺激的中性粒细胞来评估活性氧(ROS)的产生和信号通路的激活。结果:QFPDD可预防继发性感染小鼠体重减轻,降低肺指数,降低肺细菌负荷,减轻低温。ScRNA-seq分析显示,QFPDD治疗后肺部细胞因子评分下降,中性粒细胞在18个鉴定的细胞群中表现出最高的细胞因子评分。QFPDD下调中性粒细胞中的炎症介质。此外,QFPDD降低了黄嘌呤氧化酶、髓过氧化物酶、瓜氨酸组蛋白H3和肽基精氨酸脱亚胺酶4的表达,并降低了S100钙结合蛋白A8和S100钙结合蛋白A9的水平,表明QFPDD可能与NETs的形成减少有关。QFPDD还能降低血小板活化和高凝指标。在体外,QFPDD抑制巨噬细胞中细胞因子和趋化因子的产生,抑制中性粒细胞中ROS的产生和细胞外信号调节的蛋白激酶磷酸化。此外,QFPDD显著增强巨噬细胞和中性粒细胞中吞噬受体的表达。结论:QFPDD通过抑制NETs和细胞因子风暴的形成,对流感后细菌感染具有保护作用,突出了其作为进一步研究预防和治疗流感后细菌感染的候选药物的潜力。本文署名:穆建伟,程涛,胡磊,雷波,马玉华,崔莹,彭玉春,黄文文,葛玉文,何立平,郑玉军。清肺排毒汤是一种复方中草药,通过抑制中性粒细胞胞外陷阱和细胞因子风暴的形成来预防流感后细菌感染。中华医学杂志;2009;打印前Epub。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Integrative Medicine-Jim
Journal of Integrative Medicine-Jim Medicine-Complementary and Alternative Medicine
CiteScore
9.20
自引率
4.20%
发文量
3319
期刊介绍: The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine. JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI). JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en). JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor. Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community. JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书